Category: BÜHLMANN IBDoc® Assay Citations

US: BÜHLMANN IBDoc® is Not Available for Sale.
Canada: Health Canada Licence: 98903, Device class: 3
Canadian customers: A number of the publications in the citation list describe applications that are outside of product claims (Intended Use: IBDoc® is intended as an aid to the determination of the inflammatory status of the patient’s intestinal mucosa for inflammatory bowel disease (e.g. Crohn’s Disease and Ulcerative Colitis) monitoring.) thus they should be used for information only.

Apologies, but no results were found for the requested archive.

Posts by title
By subject

BÜHLMANN Laboratories AG (BL), based in Basel Switzerland, has been discovering, developing & manufacturing innovative chemistry and immunological in-vitro diagnostic (IVD) and research use only (RUO) assays for almost 50 years (circa 1976). As the United States commercial affiliate of BL, BUHLMANN Diagnostics Corp (BDC), based in Amherst, NH is committed to providing exceptional sales, support, and technical services to our clinical, discovery and basic science research laboratory customers.